| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,320 |
1,098 |
$253K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
589 |
483 |
$157K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,022 |
906 |
$144K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,762 |
2,032 |
$83K |
| 80053 |
Comprehensive metabolic panel |
1,805 |
1,547 |
$81K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
853 |
595 |
$59K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,913 |
1,488 |
$51K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
778 |
247 |
$40K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
101 |
75 |
$34K |
| 36415 |
Collection of venous blood by venipuncture |
3,993 |
2,928 |
$33K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
316 |
300 |
$30K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,383 |
1,237 |
$29K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
598 |
560 |
$21K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
751 |
600 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
180 |
161 |
$16K |
| 84443 |
Thyroid stimulating hormone (TSH) |
449 |
440 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
529 |
378 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
320 |
304 |
$13K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
121 |
102 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
450 |
443 |
$8K |
| 83880 |
|
84 |
63 |
$5K |
| 84484 |
|
84 |
59 |
$5K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
74 |
24 |
$5K |
| 85027 |
|
611 |
584 |
$4K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
30 |
14 |
$4K |
| 81000 |
|
446 |
404 |
$4K |
| 80061 |
Lipid panel |
119 |
118 |
$2K |
| 82550 |
|
88 |
58 |
$2K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
48 |
12 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
142 |
75 |
$2K |
| 81003 |
|
174 |
159 |
$2K |
| 81001 |
|
70 |
63 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
48 |
44 |
$1K |
| 82553 |
|
52 |
34 |
$1K |
| 83874 |
|
48 |
34 |
$1K |
| J3490 |
Unclassified drugs |
21 |
17 |
$557.36 |
| 36000 |
|
59 |
36 |
$537.28 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
99 |
25 |
$507.01 |
| 87807 |
|
17 |
17 |
$381.60 |
| 83690 |
|
17 |
13 |
$331.25 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
20 |
14 |
$270.33 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
16 |
14 |
$256.44 |
| 82150 |
|
16 |
12 |
$251.22 |
| 85610 |
|
31 |
24 |
$187.95 |